Penang: Penang’s medical technology (medtech) industry is rapidly emerging as one of the state’s most promising sectors, driven by strong global demand, robust local capabilities, and a well-established ecosystem.
According to BERNAMA News Agency, InvestPenang chief executive officer Datuk Loo Lee Lian highlighted that the state’s expertise in precision engineering and automation, developed through its thriving semiconductor industry, has significantly contributed to the growth of the medtech sector. The skills necessary in the semiconductor industry, such as precision and automation, are directly applicable to the production of surgical instruments, implants, and high-accuracy medical devices. Loo emphasized that medtech often demands even greater precision than the semiconductor industry.
The medtech sector also benefits from its synergies with the electrical and electronics manufacturing ecosystem, as medical devices like pacemakers, glucose monitoring systems, and diagnostic equipment rely on sophistica
ted electronic and mechanical components. Loo described the medtech sector as a ‘hidden gem’, noting that unlike the cyclical semiconductor sector, it offers steady growth and higher profit margins, allowing companies to invest more in talent training. This stability makes the sector more attractive to talent, as jobs are less susceptible to hiring freezes or retrenchments.
Globally, leading medtech clusters include the United States, Ireland, Puerto Rico, and Costa Rica, where government support has spurred industry growth over the past decade. In recent years, many companies have expanded into Asia due to rising cost pressures, policy shifts, and the region’s growing, wealthier, and ageing population. Penang, with its mature industrial base, skilled workforce, and a well-developed supplier network, is an attractive location for companies expanding into Asia.
Local participation in the sector is also increasing, with homegrown firms like Straits Orthopaedics (Mfg) Sdn Bhd and UWC Healthcare now serving the
global market. InvestPenang has facilitated growth by organizing exhibitions and engagement sessions with the Health Ministry and industry partners to showcase products and encourage inclusion in government procurement.
Despite the promising outlook, Loo acknowledged three key challenges facing medtech companies in Penang: the US Trade Agreements Act which restricts the value of Malaysian-supplied products in US government contracts, geopolitical tensions and tariffs, and ongoing supply chain disruptions. Nevertheless, Loo remains optimistic about the sector’s prospects over the next five years, revealing that InvestPenang is in discussions with several medtech companies regarding potential investments. She foresees a rise in demand for advanced medical devices due to Asia’s ageing and increasingly affluent population, with expectations of more global names entering the market, particularly in higher-end products, and aims to strengthen the role of local companies in this space.